Source: Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
M. Firat (Ankara, Turkey), N. Vardar-Yagli (Ankara, Turkey), A. Cakmak (Ankara, Turkey), M. Saglam (Ankara, Turkey), E. Calik-Kutukcu (Ankara, Turkey), D. Inal-Ince (Ankara, Turkey), L. Coplu (Ankara, Turkey). Coronaphobia and physical activity level in patients with non-cystic fibrosis bronchiectasis during COVID-19 pandemic. 346

Member's Comments

No comment yet.

Related content which might interest you: Physical activity evaluation in non-cystic fibrosis bronchiectasis patients Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Non-cystic fibrosis bronchiectasis in children Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis> Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit Source: International Congress 2018 – Orphan diseases in children Year: 2018 Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 The relationship of walking speed with clinical parameters in patients with non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE) Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID Year: 2021 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 181-198 Year: 2017 Non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Immuno-allertypes in non-cystic fibrosis  bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 38-57 Year: 2017 Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020